Strs Ohio Supernus Pharmaceuticals, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 19,700 shares of SUPN stock, worth $711,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,700

Previous 13,700 43.8%

Holding current value

$711,958

Previous $366,000 67.76%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$25.77 - $35.16 $154,620 - $210,959	6,000 Added 43.8%	19,700 $614,000
Q2 2024 Aug 05, 2024	BUY	$25.99 - $33.85 $356,063 - $463,745	13,700 New	13,700 $366,000
Q2 2023 Jul 31, 2023	BUY	$29.91 - $38.73 $44,865 - $58,094	1,500 Added 6.41%	24,900 $748,000
Q1 2023 Aug 02, 2023	SELL	$34.93 - $42.03 $52,395 - $63,045	-1,500 Reduced 6.02%	23,400 $847,000
Q1 2023 Apr 27, 2023	BUY	$34.93 - $42.03 $789,418 - $949,878	22,600 Added 2825.0%	23,400 $847,000
Q3 2022 Oct 27, 2022	BUY	$28.79 - $35.41 $23,032 - $28,327	800 New	800 $27,000
Q4 2019 Jan 24, 2020	SELL	$19.93 - $29.13 $1.79 Million - $2.62 Million	-90,000 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$32.77 - $41.99 $426,010 - $545,870	13,000 Added 16.88%	90,000 $3.15 Million
Q4 2018 Jan 23, 2019	SELL	$30.84 - $49.51 $86,352 - $138,628	-2,800 Reduced 3.51%	77,000 $2.56 Million
Q3 2018 Oct 19, 2018	SELL	$42.7 - $56.55 $64,050 - $84,825	-1,500 Reduced 1.85%	79,800 $4.02 Million
Q2 2018 Aug 06, 2018	SELL	$44.1 - $59.85 $1.82 Million - $2.47 Million	-41,200 Reduced 33.63%	81,300 $4.87 Million
Q1 2018 Apr 20, 2018	SELL	$37.15 - $46.9 $234,045 - $295,470	-6,300 Reduced 4.89%	122,500 $5.61 Million
Q4 2017 Jan 23, 2018	BUY	$36.4 - $42.6 $364,000 - $426,000	10,000 Added 8.42%	128,800 $5.13 Million
Q3 2017 Oct 23, 2017	BUY	$36.75 - $49.65 $4.37 Million - $5.9 Million	118,800	118,800 $4.75 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account